Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Miran, Kenk"'
Autor:
Linh T. Nguyen, Charlotte S. Lo, Michael Fyrsta, Jessica Nie, Jennifer Y. Yam, Pei-Hua Yen, Michael X. Le, Karen Hersey, Miran Kenk, Megan Crumbaker, Neil Fleshner, Girish Kulkarni, Robert Hamilton, Michael Jewett, Antonio Finelli, Andrew Evans, Joan Sweet, Pamela S. Ohashi, Anthony M. Joshua
Publikováno v:
Prostate Cancer, Vol 2022 (2022)
Background. The evaluation of tumour-infiltrating lymphocytes (TILs) in solid malignancies has yielded insights into immune regulation within the tumour microenvironment and has also led to the development and optimisation of adoptive T cell therapie
Externí odkaz:
https://doaj.org/article/c4ca7626d4f24677b4e9214d25a6de45
Publikováno v:
European Urology Focus. 7:513-521
Context Translational research in uro-oncology depends on the availability of high-quality biospecimens and associated data to advance precision medicine and improve clinical outcomes. Procurement, storage, and annotation of these specimens represent
Autor:
Alexandre R. Zlotta, Miran Kenk, Jason Y. Lee, Khaled Ajib, Antonio Finelli, Robert J. Hamilton, Zoe Glase, Karen Hersey, Neil Fleshner, Heidi Wagner, Girish S. Kulkarni, Katherine Lajkosz, JaimeOmar Herrera-Caceres, Mohamad Baker Berajoui, Yazan Qaoud, Ishan Aditya, Nathan Perlis
Publikováno v:
Journal of Urology. 204:1012-1018
We determined if the "bag squeeze" technique decreases pain during flexible cystoscopy in men.This single center, prospective, double-blind, randomized controlled trial recruited 200 consenting participants who were ambulatory, outpatient males who h
Autor:
Miran Kenk, Thenappan Chandrasekar, Christopher J.D. Wallis, Shabbir M.H. Alibhai, Hanan Goldberg, Girish S. Kulkarni, Linda Z. Penn, Olli Saarela, Zachary Klaassen, Alejandro Berlin, Faizan K. Mohsin, Refik Saskin, Neil Fleshner
Publikováno v:
Prostate Cancer and Prostatic Diseases. 23:622-629
Proton pump inhibitors (PPIs) are commonly prescribed medications that have been shown to have contradicting effects on cancer. We aimed to investigate the effect of pantoprazole and other PPIs on prostate cancer (PCa) specific mortality (PCSM), use
Publikováno v:
Cancers. 14(4)
Background: Prostate cancer is a leading cause of death. Approximately one in eight men who are diagnosed with prostate cancer will die of it. Since there is a large difference in mortality between low- and high-risk prostate cancers, it is critical
Autor:
Hanan Goldberg, Faizan K. Mohsin, Thenappan Chandrasekar, Christopher J.D. Wallis, Zachary Klaassen, Ardalan E. Ahmad, Refik Saskin, Miran Kenk, Olli Saarela, Girish S. Kulkarni, Shabbir M.H. Alibhai, Neil Fleshner
Publikováno v:
Can Urol Assoc J
Introduction: This was a secondary analysis aiming to assess whether hydrophilic or hydrophobic statins have a differential effect on urinary retention (UR) and lower urinary tract symptoms (LUTS) in men following a prostate biopsy (PB), who were at
Autor:
Susan Nguyen, Miran Kenk, Jacob Wise, Karen Hersey, Katherine Lajkosz, Sophie O'Halloran, Alejandro Berlin, Lauren Fleshner
Publikováno v:
Can Urol Assoc J
Introduction: In light of COVID-19, reducing patient exposure via remote monitoring is desirable. Patients prescribed abiraterone/enzalutamide are scheduled for monthly in-person appointments to screen for adverse events (AEs). We determined time tre
Autor:
Yazan Qaoud, Jaime O. Herrera-Caceres, Roman Bass, Mohamad Baker Berjaoui, Raj Tiwari, Miran Kenk, Katherine Lajkosz, Antonio Finelli, Nathan Perlis, Laurence Klotz, Neil Fleshner
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:343.e1-343.e6
Partial gland ablation (PGA) for localised prostate cancer (CaP) aims to eradicate clinically significant tumours while preserving healthy tissue, thereby decreasing the likelihood of side effects compared to whole-gland approaches. Although salvage
Autor:
Robert Nussbaum, Kirsten M. Farncombe, Danny Vesprini, Colin C. Pritchard, Johann S. de Bono, Steven A. Narod, Yvonne Bombard, Roderick Clark, Emily Thain, Justin Lorentz, Neil Fleshner, Kristen McAlpine, Raymond H. Kim, Alexander W. Wyatt, Miran Kenk
Publikováno v:
Can Urol Assoc J
Introduction: Prostate cancer is a significant cause of cancer mortality. It has been well-established that certain germline pathogenic variants confer both an increased risk of being diagnosed with prostate cancer and dying of prostate cancer.1 Ther
Autor:
Alexander Avgoustis, Ana Bolanos, Miran Kenk, Sangita Paul, Dee McGarvey, Ana Torres, Heidi Wagner, Neil Fleshner
Publikováno v:
Biopreservation and Biobanking. 19:549-550